Mindmap
Using Value Based Pricing Strategically in a Highly Competitive Market
Inhalt der Mindmap
Using Value Based Pricing Strategically in a Highly Competitive Market
#1 Some pricing fundamentals
- 1.1 Importance of pricing to bottom-line
- 1.2 What is 'value based pricing'?
- 1.4 Segmentation means working out who you will not do business with
- 1.3 Fairness effect
- 1.5 Pricing as moment of truth
#2 Thinking about pricing in pharmaceuticals
- 2.2 Alternative meanings for 'value based pricing' in pharmaceuticals
- 2.4 Pricing research through the product lifecycle
- 2.5 Market restrictions
- 2.8 Payors, physicians, and patients
- 2.3 Many different diseases, medical interventions and potential value propositions
- 2.1 Pricing and go / no go decisions - acute stroke example
- 2.6 Canadian payor "demand curve"
- 2.7 'Value based pricing' and me-toos
#3 'How to' guide to using 'value based pricing' in pharmaceuticals
- 3.1 Researching public v private payors
- 3.6 Segmentation
- 3.2 Understanding the decision-making processes
- 3.3 The good, the bad and the ugly
- 3.5 Perceived value measurement
- 3.4 Discrete choice trade-off analysis
- 3.7 Use research to sell price, not just set price
#4 Future directions
- 4.1 Expect pricing innovation
- 4.2 Bundling for integrated health propositions
- 4.3 Big Data
- 4.4 Better ways to understand how pricing changes behaviour
- 4.5 Final thoughts
Informationen
- Beschreibung
- Mindmap am Using Value Based Pricing Strategically in a Highly Competitive Market, erstellt von peter.winters am 08/05/2013.
- Erstellt von
- peter.winters
- Aufrufe
- 34
- Bewertung